# TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company
Canonical URL: https://biopharmsignal.com/news/TCBP/tcbp-announces-non-binding-letter-of-intent-to-acquire-commercial-stage-ophthalmic-pharmaceutical-company
Ticker: TCBP
Company: TC BioPharm
Source: TC BioPharm
Published: 2025-03-05 13:30 EST
Original Source URL: https://ir.tcbiopharm.com
## Article Body
No article body is available yet.
## Recent Company News
- 2025-06-11 12:30 EST — [TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient](https://biopharmsignal.com/news/TCBP/tc-biopharm-announces-complete-response-in-minimal-residual-disease-mrd-patient) — Source: TC BioPharm
- 2025-04-09 13:00 EST — [TCBP Announces Grant of European Patent for Targeting of Microbial, Oncological, and Viral Indications using Modified Gamma Delta T Cells](https://biopharmsignal.com/news/TCBP/tcbp-announces-grant-of-european-patent-for-targeting-of-microbial-oncological-and-viral-indications-using-modified-gamma-delta-t-cells) — Source: TC BioPharm
- 2025-03-21 14:45 EST — [TCBP Announces Transition from Nasdaq to OTC Markets](https://biopharmsignal.com/news/TCBP/tcbp-announces-transition-from-nasdaq-to-otc-markets) — Source: TC BioPharm
- 2025-03-18 12:03 EST — [TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead](https://biopharmsignal.com/news/TCBP/tcbp-announces-outsourcing-initiatives-reducing-burn-rate-and-overhead) — Source: TC BioPharm
- 2025-03-05 13:30 EST — [TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company](https://biopharmsignal.com/news/TCBP/tcbp-announces-non-binding-letter-of-intent-to-acquire-commercial-stage-ophthalmic-pharmaceutical-company) — Source: TC BioPharm
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)